05:46 AM EDT, 05/07/2024 (MT Newswires) -- Helius Medical Technologies ( HSDT ) said Monday it priced a public offering of 804,999 class A common shares and about 2 million pre-funded warrants, each to buy one common share together with accompanying series A and series B warrants to buy up to about 5.7 million common shares.

The price of each common share and accompanying series A and series B warrants is $2.25 and the price of each pre-funded warrant and accompanying series A and series B warrant is $2.249.

Gross proceeds from the offering, which is expected to close around Thursday, are estimated to be about $6.4 million.

Net proceeds will be used to fund operations, for working capital and other general corporate purposes.

Shares of Helius fell more than 6% in after-market hours on Monday.

Price: 2.2600, Change: -0.16, Percent Change: -6.61